Company Filing History:
Years Active: 1999
Title: Mathews Hm Noteborn: Innovator in Avian Virology
Introduction
Mathews Hm Noteborn is a prominent inventor based in Leiden, Netherlands. He has made significant contributions to the field of avian virology, particularly in the study and application of the Chicken Anemia Virus (CAV). With a total of 2 patents, his work has implications for diagnostics, vaccination, and antibody production.
Latest Patents
Noteborn's latest patents include innovative methods and compositions related to the Chicken Anemia Virus. One patent focuses on recombinant chicken anemia virus particles, which contain specific nucleotide sequences for diagnostics, vaccination, or protein production. This patent also describes the use of recombinant CAV protein for the production of CAV-specific antibodies. Another patent details the cloning of the complete CAV DNA genome, which is representative of CAV worldwide. This work enables the detection of CAV-specific sequences through PCR, enhancing the ability to validate negative PCR results and estimate the number of CAV DNA copies in samples.
Career Highlights
Mathews Hm Noteborn has established himself as a key figure in his field through his innovative research and patent contributions. His work has advanced the understanding of CAV and its applications in poultry health. He is associated with Leadd B.V., where he continues to develop solutions for avian diseases.
Collaborations
Noteborn collaborates with Gerden F De Boer, contributing to the advancement of research in avian virology. Their partnership enhances the potential for breakthroughs in diagnostics and treatment.
Conclusion
Mathews Hm Noteborn's contributions to avian virology through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the industry positively, paving the way for advancements in poultry health and disease management.